Renal Prognosis of COVID-19 Associated Nephropathy.

Giannini, Gabriel; Carlos Q Velez, Juan; May, Rebecca M; Sharma, Shree G; Mohamed, Muner M B; Cassol, Clarissa A; Larsen, Christopher P; Caza, Tiffany N

Giannini, Gabriel; Carlos Q Velez, Juan; May, Rebecca M; Sharma, Shree G; Mohamed, Muner M B; Cassol, Clarissa A; Larsen, Christopher P; Caza, Tiffany N.

Afiliação

Giannini G; Arkana Laboratories, Little Rock, Arkansas, USA.
Carlos Q Velez J; Ochsner Health, Department of Nephrology, New Orleans, Louisiana, USA.
May RM; Ochsner Clinical School, The University of Queensland (Australia), St. Lucia, Queenslamd, Australia.
Sharma SG; Arkana Laboratories, Little Rock, Arkansas, USA.
Mohamed MMB; Arkana Laboratories, Little Rock, Arkansas, USA.
Cassol CA; Ochsner Health, Department of Nephrology, New Orleans, Louisiana, USA.
Larsen CP; Ochsner Clinical School, The University of Queensland (Australia), St. Lucia, Queenslamd, Australia.
Caza TN; Arkana Laboratories, Little Rock, Arkansas, USA.

Kidney Int Rep ; 7(12): 2722-2725, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36277848

Palavras-chave

APOL1; COVAN; COVID-19 associated nephropathy; collapsing glomerulopathy; outcomes; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google